open access

Vol 9, No 3-4 (2008): Practical Diabetology
Original articles (submitted)
Published online: 2008-07-04
Get Citation

Assessment of quality of life and treatment satisfaction in patients with diagnosed diabetes mellitus and treated with insulin aspart or biphasic insulin aspart 30/70 in comparison to patients treated with human insulin

Teresa Koblik, Jacek Sieradzki, Iwona Skrzekowska-Baran
Diabetologia Praktyczna 2008;9(3-4):121-131.

open access

Vol 9, No 3-4 (2008): Practical Diabetology
Original articles (submitted)
Published online: 2008-07-04

Abstract

The aim of this analysis was to compare quality of life and treatment satisfaction of patients with diagnosed type 1 or 2 diabetes mellitus treated with insulin aspart or biphasic insulin aspart 30/70 with those of patients, to whom therapy with human insulin was administered. Quality of life and treatment satisfaction analysis for type 1 diabetes mellitus was based on a systematic review, in which efficacy and safety of insulin aspart and biphasic insulin aspart 30/70 vs. human insulin was evaluated. In addition, database search within a systematic review revealed 4 randomized, open-label clinical trials.
In order to supplement the review mentioned above and extend the analysis to other treatment protocols, the results of a study, in which the same endpoints were assessed in patients, in whom insulin aspart in combination with Hagedorn protamin insulin (NPH) was used, vs. patients treated with short-acting human insulin, also in combination with NPH, were taken into account in the analysis. In assessment of treatment satisfaction of patients with type 2 diabetes mellitus the results of another observational study were taken into account, in which the endpoints mentioned above were evaluated in patients treated with biphasic insulin aspart 30/70 as compared with several previously used treatments. The two studies mentioned above exceeded the inclusion criteria assumed for the systematic review. Extension of the inclusion criteria for this analysis made it possible to compare both quality of life and treatment satisfaction achieved with therapy with insulin aspart or biphasic insulin aspart 30/70 as compared to human insulin in different treatment protocols and in a more complete way. Treatment satisfaction was assessed using DTSQ scale/DSQOLS subscale and quality of life with specific questionnaires: DSQOLS, DHP, QLsc. Results of all the studies identified within the systematic review demonstrated higher quality of life and treatment satisfaction achieved with insulin aspart as compared to human insulin in type 1 diabetes mellitus. Treatment satisfaction for insulin aspart in combination with NPH was also higher as compared to human insulin in combination with NPH.
Therapy with biphasic insulin aspart administered by means of a pen was also evaluated higher by the patients than the treatment used prior to enrollment; this was true for total score as well as for the parts related to convenience, flexibility, efficacy, quality of life and general preferences with respect to treatment.

Abstract

The aim of this analysis was to compare quality of life and treatment satisfaction of patients with diagnosed type 1 or 2 diabetes mellitus treated with insulin aspart or biphasic insulin aspart 30/70 with those of patients, to whom therapy with human insulin was administered. Quality of life and treatment satisfaction analysis for type 1 diabetes mellitus was based on a systematic review, in which efficacy and safety of insulin aspart and biphasic insulin aspart 30/70 vs. human insulin was evaluated. In addition, database search within a systematic review revealed 4 randomized, open-label clinical trials.
In order to supplement the review mentioned above and extend the analysis to other treatment protocols, the results of a study, in which the same endpoints were assessed in patients, in whom insulin aspart in combination with Hagedorn protamin insulin (NPH) was used, vs. patients treated with short-acting human insulin, also in combination with NPH, were taken into account in the analysis. In assessment of treatment satisfaction of patients with type 2 diabetes mellitus the results of another observational study were taken into account, in which the endpoints mentioned above were evaluated in patients treated with biphasic insulin aspart 30/70 as compared with several previously used treatments. The two studies mentioned above exceeded the inclusion criteria assumed for the systematic review. Extension of the inclusion criteria for this analysis made it possible to compare both quality of life and treatment satisfaction achieved with therapy with insulin aspart or biphasic insulin aspart 30/70 as compared to human insulin in different treatment protocols and in a more complete way. Treatment satisfaction was assessed using DTSQ scale/DSQOLS subscale and quality of life with specific questionnaires: DSQOLS, DHP, QLsc. Results of all the studies identified within the systematic review demonstrated higher quality of life and treatment satisfaction achieved with insulin aspart as compared to human insulin in type 1 diabetes mellitus. Treatment satisfaction for insulin aspart in combination with NPH was also higher as compared to human insulin in combination with NPH.
Therapy with biphasic insulin aspart administered by means of a pen was also evaluated higher by the patients than the treatment used prior to enrollment; this was true for total score as well as for the parts related to convenience, flexibility, efficacy, quality of life and general preferences with respect to treatment.
Get Citation

Keywords

insulin aspart; biphasic insulin aspart; human insulin; quality of life; treatment satisfaction; type 1 and 2 diabetes mellitus

About this article
Title

Assessment of quality of life and treatment satisfaction in patients with diagnosed diabetes mellitus and treated with insulin aspart or biphasic insulin aspart 30/70 in comparison to patients treated with human insulin

Journal

Clinical Diabetology

Issue

Vol 9, No 3-4 (2008): Practical Diabetology

Pages

121-131

Published online

2008-07-04

Bibliographic record

Diabetologia Praktyczna 2008;9(3-4):121-131.

Keywords

insulin aspart
biphasic insulin aspart
human insulin
quality of life
treatment satisfaction
type 1 and 2 diabetes mellitus

Authors

Teresa Koblik
Jacek Sieradzki
Iwona Skrzekowska-Baran

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl